ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
6.00
-0.01 (-0.17%)
At close: Mar 12, 2026, 4:00 PM EDT
6.00
0.00 (0.00%)
After-hours: Mar 12, 2026, 4:00 PM EDT

ImageneBio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
94.5312.12119.8959.92232.22
Short-Term Investments
40.82-55.5797.03-
Cash & Short-Term Investments
135.3512.12175.47156.95232.22
Cash Growth
1016.92%-93.09%11.80%-32.41%42.91%
Other Current Assets
4.940.353.23.064.3
Total Current Assets
140.2912.47178.66160.01236.52
Net Property, Plant & Equipment
0.790.558.028.468.98
Other Long-Term Assets
11.92.915.413.792.39
Total Assets
152.9815.92192.09172.26247.88
Accounts Payable
1.445.292.072.092.38
Accrued Expenses
7.533.468.588.345.85
Current Portion of Long-Term Debt
-7.5---
Current Portion of Leases
2.260.313.561.911.85
Unearned Revenue
-0.65-9.1617.1
Total Current Liabilities
11.2317.2114.2121.527.19
Long-Term Leases
0.710.247.183.795.14
Other Long-Term Liabilities
7.89-0.95-7.68
Total Long-Term Liabilities
8.60.248.133.7912.81
Total Liabilities
19.8417.4522.3425.2940
Preferred Stock
-18.97---
Common Stock
0.0100.050.040.04
Additional Paid-in Capital
363.092.16452.14361.92353.3
Accumulated Other Comprehensive Income
0.09-1.79-0.05-0.76-
Retained Earnings
-230.05-179.9-282.39-214.22-145.45
Total Common Shareholders' Equity
133.14-160.57169.76146.97207.88
Minority Interest
-159.04---
Shareholders' Equity
133.14-1.53169.76146.97207.88
Total Liabilities & Equity
152.9815.92192.09172.26247.88
Total Debt
2.988.0510.745.696.99
Net Cash (Debt)
132.374.07164.73151.25225.23
Net Cash Growth
3152.43%-97.53%8.91%-32.84%38.77%
Net Cash Per Share
27.183.4147.3650.1696.58
Book Value
133.14-160.57169.76146.97207.88
Book Value Per Share
27.33-134.4648.8148.7389.14
Tangible Book Value
133.14-160.57169.76146.97207.88
Tangible Book Value Per Share
27.33-134.4648.8148.7389.14
Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q